Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Objective
This study aimed to evaluate the association of dynamic contrast enhancement (DCE) with clinically significant prostate cancer (csPCa, Gleason Grade Group ≥2) and compare biparametric magnetic resonance imaging (bpMRI) and multiparametric MRI (mpMRI) nomograms.
Subjects/patients and methods
We identified a retrospective cohort of...
Alternative Titles
Full title
Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_01b7e5c211b741d081f7b21090af0298
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_01b7e5c211b741d081f7b21090af0298
Other Identifiers
ISSN
2688-4526
E-ISSN
2688-4526
DOI
10.1002/bco2.415
